The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Defects of glucose transport and phosphorylation may underlie insulin resistance in obesity and non-insulin-dependent diabetes mellitus (NIDDM). To test this hypothesis, dynamic imaging of 18F-2-deoxy-glucose uptake into midthigh muscle was performed using positron emission tomography during basal and insulin-stimulated conditions (40 mU/m2 per min), in eight lean nondiabetic, eight obese nondiabetic, and eight obese subjects with NIDDM. In additional studies, vastus lateralis muscle was obtained by percutaneous biopsy during basal and insulin-stimulated conditions for assay of hexokinase and citrate synthase, and for immunohistochemical labeling of Glut 4. Quantitative confocal laser scanning microscopy was used to ascertain Glut 4 at the sarcolemma as an index of insulin-regulated translocation. In lean individuals, insulin stimulated a 10-fold increase of 2-deoxy-2[18F]fluoro-D-glucose (FDG) clearance into muscle and significant increases in the rate constants for inward transport and phosphorylation of FDG. In obese individuals, the rate constant for inward transport of glucose was not increased by insulin infusion and did not differ from values in NIDDM. Insulin stimulation of the rate constant for glucose phosphorylation was similar in obese and lean subjects but reduced in NIDDM. Insulin increased by nearly twofold the number and area of sites labeling for Glut 4 at the sarcolemma in lean volunteers, but in obese and NIDDM subjects translocation of Glut 4 was attenuated. Activities of skeletal muscle HK I and II were similar in lean, obese and NIDDM subjects. These in vivo and ex vivo assessments indicate that impaired glucose transport plays a key role in insulin resistance of NIDDM and obesity and that an additional impairment of glucose phosphorylation is evident in the insulin resistance of NIDDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“The “glucose clamp” method (14), determines insulin sensitivity but does not separate glucose transport and phosphorylation from subsequent steps of metabolism.”
MethodSokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418 · cited 1×
“This modeling of PET data was originally developed and then validated for brain (23), and later validated for myocardium (24).”
MethodHamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,351
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · cited 1×
“Impairment of insulin-stimulated glycogen synthesis in NIDDM (16), does not exclude a proximal impairment of glucose transport or phosphorylation, particularly since decreased skeletal muscle [G-6-P] has also been found in NIDDM (17).”
BackgroundLaakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930 · cited 1×
“The rate constant for inward transport of glucose describes the efficiency of glucose movement from blood to tissue and insulin resistance in the stimulation of blood flow (57), or factors such as reduced capillary density (58), could potentially influence the rate constant for inward transport of glucose.”
BackgroundMolecular Biology of Mammalian Glucose Transporters
Bell, G. I., Kayano, T., Buse, J. B., Burant, C. F., Takeda, J., Lin, D., Fukumoto, H., & Seino, S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.198 · Cited by 853 · cited 1×
“The structure and expression of the insulin-regulated glucose transporter, Glut 4, is normal in most individuals with obesity or NIDDM (4–7), but insulin-regulated translocation of Glut 4 was not assessed and this is essential for functional competence of Glut 4 (8, 9).”
BackgroundCellular and molecular diversities of mammalian skeletal muscle fibers
Pette, D., & Staron, R. S. (1990) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/3540528806_3 · Cited by 798 · cited 1×
“The ratio of HK to CS enzyme activity levels, an index reflecting proportionality between glycolytic and oxidative enzyme capacities (41), was highest in NIDDM (P , 0.”
BackgroundLillioja, S., Young, A. A., Culter, C. L., Ivy, J. L., Abbott, W. G., Zawadzki, J. K., Yki-Järvinen, H., Christin, L., Secomb, T. W., & Bogardus, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113088 · Cited by 782 · cited 1×
“The rate constant for inward transport of glucose describes the efficiency of glucose movement from blood to tissue and insulin resistance in the stimulation of blood flow (57), or factors such as reduced capillary density (58), could potentially influence the rate constant for inward transport of glucose.”
BackgroundSuction applied to a muscle biopsy maximizes sample size
EVANS, W. J., PHINNEY, S. D., & YOUNG, V. R. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198201000-00018 · Cited by 519 · cited 1×
“After 60 min of bed rest and before insulin infusion, a percutaneous biopsy of the vastus lateralis muscle was obtained as previously described (33).”
MethodImpaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley, D. E., & Simoneau, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117600 · Cited by 487 · cited 2×
“In a recent study, similar HK activity in muscle of nondiabetic and NIDDM subjects was also observed (13).”
BackgroundSelf-citationReivich, M., Alavi, A., Wolf, A., Fowler, J., Russell, J., Arnett, C., MacGregor, R. R., Shiue, C. Y., Atkins, H., Anand, A., et al. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.24 · Cited by 415 · cited 1×
“The LC is the ratio of analog (FDG) to true glucose utilization (22, 36).”
BackgroundGlucose Transport and Glucose Transporters in Muscle and Their Metabolic Regulation
Klip, A., & Pâquet, M. R. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.228 · Cited by 378 · cited 1×
“The structure and expression of the insulin-regulated glucose transporter, Glut 4, is normal in most individuals with obesity or NIDDM (4–7), but insulin-regulated translocation of Glut 4 was not assessed and this is essential for functional competence of Glut 4 (8, 9).”
BackgroundSimoneau, J., Colberg, S. R., Thaete, F. L., & Kelley, D. E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781930 · Cited by 362 · cited 1×
“This enzyme ratio was also negatively correlated with insulin sensitivity, and is consistent with prior observations that an elevated ratio of glycolytic to oxidative enzyme capacities is a biochemical characteristic of insulin resistant skeletal muscle (55).”
ResultSelf-citationPedersen, O., Bak, J. F., Andersen, P. H., Lund, S., Moller, D. E., Flier, J. S., & Kahn, B. B. (1990) · Diabetes · doi:10.2337/diab.39.7.865 · Cited by 329
Rothman, D. L., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115686 · Cited by 328 · cited 2×
“Impairment of insulin-stimulated glycogen synthesis in NIDDM (16), does not exclude a proximal impairment of glucose transport or phosphorylation, particularly since decreased skeletal muscle [G-6-P] has also been found in NIDDM (17).”
BackgroundSkeletal muscle utilization of free fatty acids in women with visceral obesity.
Colberg, S. R., Simoneau, J. A., Thaete, F. L., & Kelley, D. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117864 · Cited by 320 · cited 1×
“Plasma glucose radioactivity was determined with liquid scintillation spectometry after de-proteinizing plasma and evaporating supernatant to dryness to remove tritiated water, as previously described (40).”
MethodSelf-citationGlucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.
Nuutila, P., Koivisto, V. A., Knuuti, J., Ruotsalainen, U., Teräs, M., Haaparanta, M., Bergman, J., Solin, O., Voipio-Pulkki, L. M., & Wegelius, U. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115780 · Cited by 313 · cited 2×
“estimated that LC 5 1 for skeletal muscle in healthy volunteers during euglycemic insulin-stimulated condition (26).”
BackgroundDohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S. M., Elton, C. W., & Caro, J. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113622 · Cited by 296 · cited 1×
“Dohm and colleagues, in fresh incubations of human rectus abdominous muscle, found severe impairment of insulin-stimulated glucose transport in NIDDM and noted that this defect was of similar magnitude to that of individuals with marked obesity (47).”
ResultGarvey, W. T., Maianu, L., Hancock, J. A., Golichowski, A. M., & Baron, A. (1992) · Diabetes · doi:10.2337/diab.41.4.465 · Cited by 289
Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.
Kahn, B. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115724 · Cited by 286 · cited 1×
“Glucose transport is a rate-limiting step for insulin-stimulated glucose utilization in skeletal muscle (1, 2), and is a potentially important site of insulin resistance in obesity and non–insulindependent diabetes mellitus (NIDDM) 1 (3).”
BackgroundDifferential sorting of two glucose transporters expressed in insulin-sensitive cells
Piper, R. C., Hess, L. J., & James, D. E. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.260.3.c570 · Cited by 256 · cited 2×
“Subsequently, sections were incubated for 1 h in primary antibody (a rabbit polyclonal directed to Glut 4); the bindings characteristics of this antibody to Glut 4 and Glut 1, and its use in confocal laser microscopy studies of Glut 4 have been previously described (37).”
MethodNuutila, P., Knuuti, M. J., Mäki, M., Laine, H., Ruotsalainen, U., Teräs, M., Haaparanta, M., Solin, O., & Yki-Järvinen, H. (1995) · Diabetes · doi:10.2337/diab.44.1.31 · Cited by 253
Hansen, P. A., Gulve, E. A., & Holloszy, J. O. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.2.979 · Cited by 233 · cited 1×
“Frequently, 2-deoxyglucose is used for this purpose because it is minimally and slowly metabolized after phosphorylation (21).”
BackgroundZiel, F. H., Venkatesan, N., & Davidson, M. B. (1988) · Diabetes · doi:10.2337/diab.37.7.885 · Cited by 215 · cited 2×
“Glucose transport is a rate-limiting step for insulin-stimulated glucose utilization in skeletal muscle (1, 2), and is a potentially important site of insulin resistance in obesity and non–insulindependent diabetes mellitus (NIDDM) 1 (3).”
BackgroundKelley, D. E., & Mandarino, L. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114935 · Cited by 210 · cited 1×
“Insulin-stimulated FDG uptake in skeletal muscle was equivalent in hyperglycemic NIDDM and euglycemic nondiabetic subjects (43), findings consistent with hyperglycemic compensation of insulin resistance in NIDDM (44).”
ResultSelf-citationIII. Effects of Chronic Hypoxia on Muscle Enzyme Activities*
Howald, H., Pette, D., Simoneau, J.-A., Uber, A., Hoppeler, H., & Cerretelli, P. (1990) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024847 · Cited by 188
Self-citationImmunocytochemical and biochemical studies of GLUT4 in rat skeletal muscle.
Rodnick, K. J., Slot, J. W., Studelska, D. R., Hanpeter, D. E., Robinson, L. J., Geuze, H. J., & James, D. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42692-0 · Cited by 180 · cited 1×
“High resolution structural microscopy has previously been used to study insulin-regulated Glut 4 translocation in muscle (37, 49).”
MethodKatzen, H. M., Soderman, D. D., & Wiley, C. E. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62888-1 · Cited by 169
Garvey, W. T., Huecksteadt, T. P., Matthaei, S., & Olefsky, J. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113485 · Cited by 169 · cited 1×
“reported reduced number and activity of glucose transporters in primary cultures of adipocytes from obese and NIDDM subjects (46).”
BackgroundFinegood, D. T., Bergman, R. N., & Vranic, M. (1988) · Diabetes · doi:10.2337/diab.37.8.1025 · Cited by 159 · cited 2×
“3-[ 3 H]Glucose was added to the D 20 infusion in order to maintain stable plasma glucose specific activity (34).”
MethodTransmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.
Bonadonna, R. C., Del Prato, S., Saccomani, M. P., Bonora, E., Gulli, G., Ferrannini, E., Bier, D., Cobelli, C., & DeFronzo, R. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116592 · Cited by 149 · cited 3×
“, using a novel isotope and limb balance approach, found defects in both transport and phosphorylation in NIDDM (19, 20).”
BackgroundMethodEffects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans
Kelley, D. E., Reilly, J. P., Veneman, T., & Mandarino, L. J. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.6.e923 · Cited by 136 · cited 1×
“This occurred in conjunction with a 10-fold stimulation of FDG clearance by muscle of lean volunteers, a finding similar to leg balance studies of insulin action on glucose uptake (42).”
ResultSelf-citationDevelopment and regulation of glucose transporter and hexokinase expression in rat
Postic, C., Leturque, A., Printz, R. L., Maulard, P., Loizeau, M., Granner, D. K., & Girard, J. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.4.e548 · Cited by 127 · cited 1×
“In the current study, approximately two-thirds of skeletal muscle hexokinase activity was attributable to hexokinase II, which is consistent with known patterns of expression in muscle (52).”
ResultSelberg, O., Burchert, W., vd Hoff, J., Meyer, G. J., Hundeshagen, H., Radoch, E., Balks, H. J., & Müller, M. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116407 · Cited by 117 · cited 2×
“found that individuals with cirrhosis had reduced K1, increased k2, and no difference in k3 in skeletal muscle as compared with values in healthy volunteers (30).”
BackgroundResultOhtake, T., Yokoyama, I., Watanabe, T., Momose, T., Serezawa, T., Nishikawa, J., & Sasaki, Y. (1995) · PubMed · Cited by 106
Voipio‐Pulkki, L., Nuutila, P., Knuuti, J. M., Ruotsalainen, U., Haaparanta‐Solin, M., Teräs, M., Wegelius, U., & Koivisto, V. A. (1993) · PubMed · Cited by 104
Glucose Transport in Human Skeletal Muscle: The In Vivo Response to Insulin
Bonadonna, R. C., Saccomani, M. P., Seely, L., Zych, K. S., Ferrannini, E., Cobelli, C., & DeFronzo, R. A. (1993) · Diabetes · doi:10.2337/diab.42.1.191 · Cited by 102 · cited 1×
“, using forearm balance with isotope methods have examined the kinetics of insulin-stimulated glucose transport in muscle (18), and find impairment of glucose transport (19) and phosphorylation (20) in NIDDM.”
MethodInsulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle
Guma, A., Zierath, J. R., Wallberg-Henriksson, H., & Klip, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.4.e613 · Cited by 101 · cited 1×
“6-fold insulinstimulated increment in Glut 4 within plasma membranes based on sub-cellular fractionation methods (50).”
MethodInsulin action on heart and skeletal muscle glucose uptake in essential hypertension.
Nuutila, P., Mäki, M. T., Laine, H. K., Knuuti, J. M., Ruotsalainen, U., Luotolahti, M., Haaparanta‐Solin, M., Solin, O. H., Jula, A. M., & Koivisto, V. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118085 · Cited by 86
No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia
Katz, A., Nyomba, B. L., & Bogardus, C. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e942 · Cited by 81 · cited 2×
“Glucose transport is a rate-limiting step for insulin-stimulated glucose utilization in skeletal muscle (1, 2), and is a potentially important site of insulin resistance in obesity and non–insulindependent diabetes mellitus (NIDDM) 1 (3).”
BackgroundSuction applied to a muscle biopsy maximizes sample size
EVANS, W. J., PHINNEY, S. D., & YOUNG, V. R. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198214010-00018 · Cited by 78
Pedersen, O., Bak, J. F., Andersen, P. H., et al. (1990) · Diabetes · doi:10.2337/diabetes.39.7.865 · Cited by 76
Kong, X., Manchester, J., Salmons, S., & Lawrence, J. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99969-2 · Cited by 72
Garvey, W. T., Maianu, L., Hancock, J. A., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.4.465 · Cited by 71
Molecular Scanning of Insulin-Responsive Glucose Transporter (GLUT4) Gene in NIDDM Subjects
Choi, W.-H., O'Rahilly, S., Buse, J. B., Rees, A., Morgan, R., Flier, J. S., & Moller, D. E. (1991) · Diabetes · doi:10.2337/diab.40.12.1712 · Cited by 70
Glucose transport: locus of muscle insulin resistance in obese Zucker rats
Sherman, W. M., Katz, A. L., Cutler, C. L., Withers, R. T., & Ivy, J. L. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.3.e374 · Cited by 69
Amino Acid Substitutions in Hexokinase II Among Patients With NIDDM
Laakso, M., Malkki, M., & Deeb, S. S. (1995) · Diabetes · doi:10.2337/diab.44.3.330 · Cited by 66
Hofmann, S., & Pette, D. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19942.x · Cited by 64
Ziel, F. H., Venkatesan, N., & Davidson, M. B. (1988) · Diabetes · doi:10.2337/diabetes.37.7.885 · Cited by 62
The insulin action-fiber type relationship in humans is muscle group specific
Hickey, M. S., Weidner, M. D., Gavigan, K. E., Zheng, D., Tyndall, G. L., & Houmard, J. A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.1.e150 · Cited by 54 · cited 1×
“The correlation between skeletal muscle CS activity and the rate-constant for inward transport of glucose is also consistent with the concept that muscle fibers with enhanced oxidative capacity manifest increased insulin sensitivity (56).”
ResultBaroni, M. G., Oelbaum, R. S., Pozzilli, P., Stocks, J., Li, S., Fiore, V., & Galton, D. J. (1992) · Human Genetics · doi:10.1007/bf00219344 · Cited by 44
Butler, P. C., Kryshak, E. J., Marsh, M., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.11.1373 · Cited by 39 · cited 1×
“(15), using a combination of isotope and indirect calorimetry determinations of insulin regulated glucose oxidation.”
MethodDt, F., Bergman, R. N., & Vranić, M. (1988) · Diabetes · doi:10.2337/diabetes.37.8.1025 · Cited by 36
Echwald, S. M., Bjørbaek, C., Hansen, T., Clausen, J. O., Vestergaard, H., Zierath, J. R., Printz, R. L., Granner, D. K., & Pedersen, O. (1995) · Diabetes · doi:10.2337/diab.44.3.347 · Cited by 34
2-deoxy-2-[18F]fluoro-d-glucose for metabolic studies: Current status
Fowler, J. S., & Wolf, A. P. (1986) · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · doi:10.1016/0883-2889(86)90259-5 · Cited by 33 · cited 1×
“The LC is the ratio of analog (FDG) to true glucose utilization (22, 36).”
BackgroundAnnane, D., Duboc, D., Mazoyer, B. M., Merlet, P., Fiorelli, M., Eymard, B., Radvanyi, H., Junien, C., Fardeau, M., & Gajdos, P. (1994) · Circulation · doi:10.1161/01.cir.90.6.2629 · Cited by 28 · cited 2×
“Conversely, in PET studies of patients with muscular dystrophy, a reduction in the rate constant for glucose phosphorylation was found and this correlated with the length of mutation in DNA encoding for a protein kinase (31).”
BackgroundGlucose transport in human skeletal muscle. The in vivo response to insulin
Bonadonna, R. C., Saccomani, M. P., Seely, L., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.1.191 · Cited by 24
Amino acid substitutions in hexokinase II among patients with NIDDM
Laakso, M., Malkki, M., & Deeb, S. S. (1995) · Diabetes · doi:10.2337/diabetes.44.3.330 · Cited by 21
Huang, S. C., Williams, B. A., Barrio, J. R., Krivokapich, J., Nissenson, C. H. K., Hoffman, E. J., & Phelps, M. E. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80770-6 · Cited by 20 · cited 3×
“A three compartment model (24) for FDG tissue activity in skeletal muscle was used to derive rate constants of 18 FDG uptake, transport and phosphorylation; this model was originally developed by Sokoloff et al.”
MethodVidal‐Puig, A., Printz, R. L., STRATTON, I. M., Granner, D. K., & Moller, D. E. (1995) · Diabetes · doi:10.2337/diab.44.3.340 · Cited by 18
Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects
Choi, W. H., O'Rahilly, S., Buse, J. B., et al. (1991) · Diabetes · doi:10.2337/diabetes.40.12.1712 · Cited by 15
Butler, P. C., Kryshak, E. J., Marsh, M., et al. (1990) · Diabetes · doi:10.2337/diabetes.39.11.1373 · Cited by 14
Mossberg, K. A., & Taegtmeyer, H. (1992) · PubMed · Cited by 10
Echwald, S. M., Bjørbæk, C., Hansen, T., et al. (1995) · Diabetes · doi:10.2337/diabetes.44.3.347 · Cited by 9
Katz, A., & Raz, I. (1994) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1994.tb09775.x · Cited by 7 · cited 1×
“also found that insulin infusion did not acutely stimulate HK activity in healthy volunteers, and did not affect HK distribution between cytosolic and mitochondrial fraction (54).”
Background
Cited by
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
“Individuals with diabetes also have a decreased rate constant for glucose phosphorylation, which is then followed by an approximately 50% reduction in both the rate of muscle glycogen synthesis and glucose oxidation (258, 259).”
BackgroundCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
“Diabetes 51: 2944–2950, 2002 Metabolism of both glucose and fatty acids by skeletal muscle is impaired in type 2 diabetes (1,2).”
BackgroundSelf-citationMcGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
“diabetes (19). The same principle was established in obese nondiabetic and diabetic humans by Kelley et al. ( 20 ), although in this study an additional impairment of glucose phosphorylation appeared to exist in the diabetic subjects.”
BackgroundInsulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Metadata
- Authors
- Kelley, D. E., Mintun, M. A., Watkins, S. C., Simoneau, J. A., Jadali, F., Fredrickson, A., Beattie, J., & Thériault, R.
- Affiliations
- University of Pittsburgh (US)
- United States Department of Veterans Affairs (US)
- Université Laval (CA)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-15
- Volume
- 97
- Issue
- 12
- Pages
- 2705-2713
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507362
- OpenAlex
- W2069960997
- Cited by
- 228
- References
- 58
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 8
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Université Laval
- University of Pittsburgh
- National Institutes of Health (5p30dk046204-15)
- National Institute of Diabetes and Digestive and Kidney Diseases (1P30DK-46204)
- National Center for Research Resources (M01RR000056, 5 MO1 RR 00056)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, obesity, insulin resistance, skeletal muscle, glucose transport, glucose phosphorylation, GLUT4 translocation, hexokinase, citrate synthase, FDG uptake, insulin-stimulated glucose uptake
- MeSH terms
- Adult, Biological Transport, Citrate (si)-Synthase, Diabetes Mellitus, Type 2, Glucose, Hexokinase, Humans, Insulin, Middle Aged, Monosaccharide Transport Proteins, Muscle Proteins, Obesity, Phosphorylation, Tomography, Emission-Computed, Muscle, Skeletal, Glucose Transporter Type 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.